SelfieDAO

Revolutionizing Retinal Diagnostics with AI

www.selfieai.world

Confidential | For Investor Use Only

Disclaimer

Private & Confidential

The information in these documents is confidential and privileged, intended only for the designated recipient. Unauthorized use, publication, or redistribution without Selfie Ai Sdn. Bhd.'s written consent is strictly prohibited.

The contents, which may include facts and opinions, are subject to change. While accuracy is ensured, you should seek independent advice before making investment decisions.

Selfie Ai Sdn. Bhd. makes no representations or warranties, express or implied, and is not responsible or liable for any loss, damage, costs, or expenses incurred by you as a result of relying on the information provided.

Vision & Mission

Vision

To redefine preventive healthcare by enabling everyone to assess their health status through a selfie.

Mission

To eliminate diabetic blindness by making early-stage retinopathy screening accessible, affordable, and AI-powered through mobile devices.

The Brand – "Selfie AI"

Brand Essence

Selfie AI embodies a transformative approach to preventive healthcare, merging advanced AI technology with the simplicity of a selfie. Our brand stands at the intersection of innovation and accessibility, aiming to democratize health diagnostics.

Core Values

Empowerment

Enabling individuals to take charge of their health through accessible technology.

Innovation

Continuously advancing AI capabilities to provide accurate and timely diagnostics.

Accessibility

Breaking down barriers to healthcare by offering affordable and user-friendly solutions.

Visual Identity

Logo

The Selfie AI logo features a sleek, modern design with a stylized Selfie icon, symbolizing precision and clarity in diagnostics.

Tagline

"Your Health. One Selfie Away."

Brand Personality

Selfie AI is forward-thinking, trustworthy, and compassionate. We strive to make complex health diagnostics simple and available to all, ensuring early detection and better health outcomes.

Global Crisis – Preventable Blindness from Diabetes

The Problem: A Growing, Global Epidemic

  • Over 463 million people worldwide are living with diabetes.
  • 1 in 3 of them will develop diabetic retinopathy, the leading cause of preventable blindness in working-age adults.
  • Every 6 seconds, someone goes blind due to undetected diabetic eye disease.

The real issue?

  • Retinal screening is still inaccessible, expensive, and specialist-dependent.
  • In low- and middle-income countries, access to early detection is almost non-existent.
  • Billions of dollars are lost each year due to productivity loss, disability, and treatment costs for late-stage blindness.

The Opportunity: Selfie AI Is Solving What Healthcare Systems Cannot

  • Selfie AI eliminates the dependency on specialists by combining portable fundus imaging with real-time AI engine which detects diabetic retinopathy
  • Screens patients in under a minute at the bare minimum cost
  • Operable by non-specialists, deployable in any clinic or outreach center
  • Designed for mass deployment, national health programs, and global NGO partners

Market Size & Opportunity

Global Diabetes & DR Landscape

537 million diabetics worldwide (IDF, 2023)

TAM: $52.5B

Based on 179M needing annual DR screening

Southeast Asia (SAM)

90 million diabetics across SEA

SAM: $5.4B

Annual diagnostic need at ~$30 per patient

Malaysia (SOM)

3.9 million Malaysians with diabetes

SOM: $45M/year

RM 10 per screening + RM 150/month leasing

Forecast Distribution (Assumption for Malaysia)

DR Stage % of Diabetic Patients Avg Screenings/Year Estimated Screenings (per 1M Diabetics)
No DR / Mild NPDR 60% 1 600,000
Moderate NPDR 20% 2 400,000
Severe NPDR / PDR / DME 15% 3–4 525,000
Treated / Monitoring 5% 3 150,000
Total Avg / Diabetic — ~1.75 ~1.75M scans/year per 1M diabetics

Key Takeaways

  • Average across all DR stages: 1.5 to 1.75 screenings per diabetic per year
  • Patients with vision-threatening DR require 2–4 screenings/year
  • Selfie AI's affordable model (RM 10/screen) supports frequent monitoring, especially for high-risk groups without burdening the system

Solution: Selfie AI

Selfie AI transforms this scenario with:

  • A portable smartphone-compatible fundus camera
  • Integrated with a YOLOv5-based AI detection engine
  • That identifies key retinal markers like microaneurysms, hemorrhages, and vessel anomalies
  • Delivers results in real-time on the device
  • And securely syncs data to a cloud platform that's EMR-ready and referral-enabled

System Flow Description

  1. 1
    Initiation: A healthcare worker opens the Selfie AI mobile app and captures a retinal image using the attached fundus camera.
  2. 2
    Processing: The image is processed by the YOLOv5 inference engine, either on-device (edge) or via cloud inference.
  3. 3
    Result Display: Results appear within seconds on the screen, showing the risk level and whether a referral is needed.
  4. 4
    Storage & Sync: Data is stored locally and then synced to the cloud-based database when internet connectivity is available.
  5. 5
    EMR Integration: Results can be pushed to the clinic's electronic medical records (EMR) system using FHIR-compatible APIs.

Visual Representation

(Diagram would show the complete flow from image capture to EMR integration with AI processing in between)

Business Model & Revenue Streams

Revenue Stream Model Price/Unit Description
API-based screening Per scan RM 10 Real-time AI analysis charged per diagnostic session
Device leasing Monthly RM 150/device Camera + app license bundled into recurring lease
Institutional licensing Annual RM 10,000–50,000 Tiered licenses for NGOs, public hospitals, and group clinics
Dashboard Analytics Subscription RM 500–2,000/month Insights into patient trends, location coverage, etc.
EMR Integration One-time + support RM 3,000–15,000 Setup and maintenance of custom integrations

Government & Public Health Opportunity (Malaysia Focus)

Why Selfie AI is a Strategic Fit for the Malaysian Government:

  • Over 3.9 million diabetics, many undiagnosed for DR.
  • Only 26% undergo eye screening annually.
  • Rural Klinik Kesihatan centers lack specialists or access to diagnostic equipment.

How Selfie AI Helps:

  • Empowers Klinik Kesihatan, mobile outreach, and state health clinics to run scalable DR screening with non-specialist staff.
  • Real-time results reduce bottlenecks and improve referral accuracy.
  • Data is EMR-ready, with sync to state or federal health systems.

Government Revenue Potential

Engagement Type Value Proposition Estimated Contract Size
MOH Diabetic Screening Pilot Deploy Selfie AI across 100 clinics RM 1.5M–3M
State-level DR Programs Leased devices + API use RM 200K–500K/state
PPP Model Selfie AI handles infrastructure, govt funds scans RM 10M+ nationally over 2–3 years

Selfie AI's Unfair Advantage

Embedded AI + Field-Ready Simplicity = Scalable Diagnostic Infrastructure Without the Infrastructure

1. Deep Tech + Deployment Simplicity

Selfie AI uniquely combines a YOLOv5-trained deep learning model with a smartphone-compatible fundus camera, delivering real-time diagnostic-grade diabetic retinopathy detection—without the need for a specialist or high-end infrastructure.

2. First-Mover in LMIC-Compatible AI Diagnostics

While AI diagnostics exist, few can run offline, deliver under RM 10 per scan, operate without doctors or Wi-Fi, and be embedded seamlessly into public health systems. Selfie AI is designed from the ground up for emerging markets.

3. Data Flywheel + Regulatory Edge

Each scan helps rettrain and refine the model with localized population data, creating a data moat specific to Southeast Asia's diabetic population. Once integrated into EMR systems and public health programs, Selfie AI becomes a critical part of the government's screening infrastructure.

4. Unfair Advantage Summary

YOLOv5 model on mobile Real-time AI inference on low-resource devices
No specialist needed Breaks dependency on ophthalmologists
RM 10 scan price 5–10x cheaper than clinics; scalable for government adoption
Offline-first architecture Operates in rural clinics and syncs data later

This is not just a product. It's a new healthcare layer—built for billions—without needing hospitals. That's Selfie AI's unfair advantage.

Selfie AI Strategic Roadmap

Phase 1: Product Fine-Tuning & First Revenue (0–6 Months)

Objectives:

  • Refine and harden the core product before scaling
  • Deploy initial pilots in private clinics and NGOs
  • Start generating revenue

Milestones:

  • Finalize YOLOv5 v1.0 model with Malaysian training data
  • Launch Selfie AI mobile app (MVP) with offline-first functionality
  • Integrate and test with 2 mobile fundus camera models

Phase 2: Private Sector Scaling (6–12 Months)

Objectives:

  • Expand reach in revenue-generating channels
  • Collect more data for AI improvement
  • Establish strong case studies and success metrics

Milestones:

  • Scale to 100+ private GP clinics and NGOs across Malaysia
  • Launch Training & Certification Portal for non-specialist operators
  • Expand EMR integration to 5+ commercial partners

Phase 3: Government Affiliation & Contracts (12–24 Months)

Objectives:

  • Align with Ministry of Health (MOH) priorities
  • Execute funded pilots to demonstrate national scalability
  • Secure state and national contracts

Milestones:

  • Secure 2 Klinik Kesihatan pilots via MOH/state collaboration
  • Complete MDA certification for medical AI deployment
  • Formalize partnerships with two states

Parallel Workstreams (Across All Phases)

AI & Data

Continuous model retraining with localized scans; version upgrades to v2.0+

Dashboard & Reporting

Build real-time reporting for clinics, NGOs, and government agencies

Grants & Fundraising

Apply to WHO, Gates Foundation, ADB, and Malaysian Innovation grants

Referral Engine

Integrate alerts and smart triage into patient flows

Global Exit Benchmarks in Digital Diagnostics & AI Healthcare

Acquired Companies & Valuations

Company Acquired By Value (USD)
Zebra Medical Vision Nanox Up to $200M
Lunit (Acquirer) Acquired Volpara Health $193M
iCAD Inc. RadNet $103M
Thirona Retina Revenio Group ~$5.2M

Average Valuation of Exits ≥ USD 100M

Considering only the high-value deals (Zebra, Lunit's acquisition of Volpara, iCAD):

Average Acquisition Valuation: $165.3M USD

Insight for Investors in Selfie AI:

  • Validated category: AI-driven diagnostics (especially in imaging) is a proven exit domain
  • Exit valuations typically range between $100M–$200M
  • Selfie AI—targeting a public health-critical issue with a scalable model—aligns well with these success patterns

Benchmark Metrics

1. Average Return Multiple for Early Investors

Benchmark: Early-stage investors (Seed to Series A) in successful digital health exits have realized average return multiples ranging from 5x to 10x.

2. Average Time from Incorporation to Exit

Benchmark: Approximately 9.5 years on average for acquisitions, with a median of 8 years.

3. Average Expected Exit Valuation

Benchmark: Successful exits in the AI healthcare diagnostics sector have achieved valuations between $300 million and $500 million.

Projected Returns for Selfie AI Investors

Assuming Selfie AI achieves 10% of the industry average exit valuation:

Projected Exit Valuation: $30 million

Seed Investors

Assuming an initial valuation of $3 million, a $30 million exit would yield a 10x return.

Series A Investors

Assuming an entry valuation of $10 million, a $30 million exit would yield a 3x return.

Technology Stack

AI Model

YOLOv5 (Medical Optimized)

Device

Mobile-compatible fundus camera

App Layer

Flutter, NextJS

Cloud Infra

AWS, Docker, Cognito

Security

HIPAA-compliant, encrypted APIs

Analytics

Real-time usage dashboards for partners

Team

Dr Kavitha

Domain expertise & Innovation

Damodharan Vijayaragavan

Operations & Partnerships

Dr. Anand Thirunavukarasu

Project Director

Dr. Dheena S

AI & Clinical Science

Francis Xavier

Tech Architecture

Abhishek Chakrala

Product Manager

Advisors

Dr. Radha Krishnan

Chief Scientist

Dr. Bharat Kumar

Retinal Specialist

Dr. Olena Pokryshko

Global Validation

Senthil Rajendran

Financial Advisor

Revenue Forecast (3 Years)

RM 8M
Year 1
RM 25M
Year 2
RM 42M
Year 3
Year API Revenue (RM) Leasing (RM) Total Revenue (RM)
Year 1 8M 2M 10M
Year 2 25M 5M 30M
Year 3 42M 8M 50M

Investment Ask

SAFE Round (YC terms)

Target:

USD 300,000

Valuation Cap:

USD 3.5M

MFN Clause:

Applicable

Use of Funds

Tech refinement and MDA approvals

30%

Market entry in 3 Malaysian states

40%

Talent onboarding and operations

30%

Shareholders Cap Table

ESOP 10%
Dr Kavitha 60%
Damo 20%
CTO 10%
ESOP 10%

Let's Build the Future of Healthcare Together

Your Health. One Selfie Away.

Contact Us

Selfie AI

www.selfieai.world

Email: damo@selfieai.world | raj@selfieai.world

Thank you for your time and consideration

Made with DeepSite LogoDeepSite - 🧬 Remix